These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 27049690)

  • 1. Fcγ1 fragment of IgG1 as a powerful affinity tag in recombinant Fc-fusion proteins: immunological, biochemical and therapeutic properties.
    Soleimanpour S; Hassannia T; Motiee M; Amini AA; Rezaee SA
    Crit Rev Biotechnol; 2017 May; 37(3):371-392. PubMed ID: 27049690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fc fusion as a platform technology: potential for modulating immunogenicity.
    Levin D; Golding B; Strome SE; Sauna ZE
    Trends Biotechnol; 2015 Jan; 33(1):27-34. PubMed ID: 25488117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of Mycobacterium tuberculosis ESAT-6 fused to human Fcγ of IgG1: To target FcγR as a delivery system for enhancement of immunogenicity.
    Soleimanpour S; Mohammadi A; Ghazvini K; Jamehdar SA; Sadeghian H; Taghiabadi M; Rezaee SAR
    Gene; 2016 Apr; 580(2):111-117. PubMed ID: 26778208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal fusion of antibody binding domains resulted in higher affinity and wider specificity.
    Dong J; Kojima T; Ohashi H; Ueda H
    J Biosci Bioeng; 2015 Nov; 120(5):504-9. PubMed ID: 25910963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor-Fc fusion therapeutics, traps, and MIMETIBODY technology.
    Huang C
    Curr Opin Biotechnol; 2009 Dec; 20(6):692-9. PubMed ID: 19889530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the Fc-III-4C-based recombinant protein expression system by using carbonic anhydrase as the model protein.
    Gong Y; Yi M; Zhang L; Feng S; Deng H
    Protein Expr Purif; 2021 Jan; 177():105761. PubMed ID: 32956801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of tag protein fusions: from molecular and biochemical fundamentals to commercial systems.
    Terpe K
    Appl Microbiol Biotechnol; 2003 Jan; 60(5):523-33. PubMed ID: 12536251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of neonatal FcR in regulating the serum half-life of therapeutic proteins containing the Fc domain of human IgG1: a comparative study of the affinity of monoclonal antibodies and Fc-fusion proteins to human neonatal FcR.
    Suzuki T; Ishii-Watabe A; Tada M; Kobayashi T; Kanayasu-Toyoda T; Kawanishi T; Yamaguchi T
    J Immunol; 2010 Feb; 184(4):1968-76. PubMed ID: 20083659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of the Fc fusion format to generate tag-free bi-specific diabodies.
    Asano R; Ikoma K; Kawaguchi H; Ishiyama Y; Nakanishi T; Umetsu M; Hayashi H; Katayose Y; Unno M; Kudo T; Kumagai I
    FEBS J; 2010 Jan; 277(2):477-87. PubMed ID: 20015073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications for an engineered Protein-G variant with a pH controllable affinity to antibody fragments.
    Bailey LJ; Sheehy KM; Hoey RJ; Schaefer ZP; Ura M; Kossiakoff AA
    J Immunol Methods; 2014 Dec; 415():24-30. PubMed ID: 25450256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Horse cytokine/IgG fusion proteins--mammalian expression of biologically active cytokines and a system to verify antibody specificity to equine cytokines.
    Wagner B; Robeson J; McCracken M; Wattrang E; Antczak DF
    Vet Immunol Immunopathol; 2005 May; 105(1-2):1-14. PubMed ID: 15797470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The covalent SNAP tag for protein display quantification and low-pH protein engineering.
    Jin W; Madan B; Mussman BK; Hailemariam AT; Fahad AS; Wolfe JR; Kwon YD; Zhang B; Shapiro L; Kwong PD; DeKosky BJ
    J Biotechnol; 2020 Aug; 320():50-56. PubMed ID: 32561362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The binding affinity of a soluble TCR-Fc fusion protein is significantly improved by crosslinkage with an anti-Cβ antibody.
    Ozawa T; Horii M; Kobayashi E; Jin A; Kishi H; Muraguchi A
    Biochem Biophys Res Commun; 2012 Jun; 422(2):245-9. PubMed ID: 22575452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current strategies for the use of affinity tags and tag removal for the purification of recombinant proteins.
    Arnau J; Lauritzen C; Petersen GE; Pedersen J
    Protein Expr Purif; 2006 Jul; 48(1):1-13. PubMed ID: 16427311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Split intein facilitated tag affinity purification for recombinant proteins with controllable tag removal by inducible auto-cleavage.
    Lu W; Sun Z; Tang Y; Chen J; Tang F; Zhang J; Liu JN
    J Chromatogr A; 2011 May; 1218(18):2553-60. PubMed ID: 21397239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pH, temperature, and salt on the stability of Escherichia coli- and Chinese hamster ovary cell-derived IgG1 Fc.
    Li CH; Narhi LO; Wen J; Dimitrova M; Wen ZQ; Li J; Pollastrini J; Nguyen X; Tsuruda T; Jiang Y
    Biochemistry; 2012 Dec; 51(50):10056-65. PubMed ID: 23078371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the assessment and control of the effector functions of therapeutic antibodies.
    Jiang XR; Song A; Bergelson S; Arroll T; Parekh B; May K; Chung S; Strouse R; Mire-Sluis A; Schenerman M
    Nat Rev Drug Discov; 2011 Feb; 10(2):101-11. PubMed ID: 21283105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbations.
    Vafa O; Gilliland GL; Brezski RJ; Strake B; Wilkinson T; Lacy ER; Scallon B; Teplyakov A; Malia TJ; Strohl WR
    Methods; 2014 Jan; 65(1):114-26. PubMed ID: 23872058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The AviD-tag, a NeutrAvidin/avidin specific peptide affinity tag for the immobilization and purification of recombinant proteins.
    Gaj T; Meyer SC; Ghosh I
    Protein Expr Purif; 2007 Nov; 56(1):54-61. PubMed ID: 17697784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural analysis of Fc/FcγR complexes: a blueprint for antibody design.
    Caaveiro JM; Kiyoshi M; Tsumoto K
    Immunol Rev; 2015 Nov; 268(1):201-21. PubMed ID: 26497522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.